Earnings Feed
Start Free
Home/Filings/4/0001209191-14-001930
4//SEC Filing

SANTARUS INC 4

Accession 0001209191-14-001930

CIK 0001172480operating
View on SEC.govCompany Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:27 PM ET

Size

65.9 KB

Accession

0001209191-14-001930

Insider Transaction Report

Form 4
Period: 2014-01-02
SANTARUS INCSNTS
HALL WARREN E
Sr. VP, Mfg. & Prod. Dev.
Transactions
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−4,219→ 63,281 total
    Exercise: $3.33Exp: 2021-03-10→ Common Stock (4,219 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$28.67/sh−63,281$1,814,266→ 0 total
    Exercise: $3.33Exp: 2021-03-10→ Common Stock (63,281 underlying)
  • Award

    Common Stock

    2014-01-02$1.18/sh+25,121$29,643→ 155,369 total
  • Tax Payment

    Common Stock

    2014-01-02$32.00/sh−7,630$244,160→ 203,791 total
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$16.58/sh−93,750$1,554,375→ 0 total
    Exercise: $15.42Exp: 2023-03-11→ Common Stock (93,750 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−3,963→ 97,287 total
    Exercise: $4.93Exp: 2022-03-12→ Common Stock (3,963 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$27.07/sh−97,287$2,633,559→ 0 total
    Exercise: $4.93Exp: 2022-03-12→ Common Stock (97,287 underlying)
  • Award

    Common Stock

    2014-01-02$6.79/sh+13,958$94,775→ 80,420 total
  • Award

    Common Stock

    2014-01-02$6.90/sh+16,816$116,030→ 97,236 total
  • Award

    Common Stock

    2014-01-02$2.36/sh+33,012$77,908→ 130,248 total
  • Award

    Common Stock

    2014-01-02$4.93/sh+3,963$19,538→ 211,421 total
  • Award

    Common Stock

    2014-01-02$4.63/sh+38,412$177,848→ 193,781 total
  • Award

    Common Stock

    2014-01-02$3.33/sh+9,458$31,495→ 203,239 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−9,458→ 55,948 total
    Exercise: $3.33Exp: 2021-03-10→ Common Stock (9,458 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$28.67/sh−55,948$1,604,029→ 0 total
    Exercise: $3.33Exp: 2021-03-10→ Common Stock (55,948 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−38,412→ 82,244 total
    Exercise: $4.63Exp: 2020-03-10→ Common Stock (38,412 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$27.37/sh−82,244$2,251,018→ 0 total
    Exercise: $4.63Exp: 2020-03-10→ Common Stock (82,244 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−58,208→ 6,792 total
    Exercise: $7.15Exp: 2015-02-15→ Common Stock (58,208 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$24.85/sh−6,792$168,781→ 0 total
    Exercise: $7.15Exp: 2015-02-15→ Common Stock (6,792 underlying)
  • Disposition to Issuer

    Common Stock

    2014-01-02$32.00/sh−203,791$6,521,312→ 0 total
  • Award

    Common Stock

    2014-01-02$7.15/sh+58,208$416,187→ 66,462 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−25,121→ 0 total
    Exercise: $1.18Exp: 2019-03-16→ Common Stock (25,121 underlying)
  • Award

    Common Stock

    2014-01-02$3.33/sh+4,219$14,049→ 207,458 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−33,012→ 72,613 total
    Exercise: $2.36Exp: 2018-03-13→ Common Stock (33,012 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−13,958→ 36,042 total
    Exercise: $6.79Exp: 2016-02-09→ Common Stock (13,958 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$29.64/sh−72,613$2,152,249→ 0 total
    Exercise: $2.36Exp: 2018-03-13→ Common Stock (72,613 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$29.64/sh−20,000$592,800→ 0 total
    Exercise: $2.36Exp: 2018-03-13→ Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-01-02−16,816→ 53,184 total
    Exercise: $6.90Exp: 2017-03-12→ Common Stock (16,816 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$25.10/sh−53,184$1,334,918→ 0 total
    Exercise: $6.90Exp: 2017-03-12→ Common Stock (53,184 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$25.21/sh−36,042$908,619→ 0 total
    Exercise: $6.79Exp: 2016-02-09→ Common Stock (36,042 underlying)
  • Disposition to Issuer

    Stock Options (right to buy)

    2014-01-02$25.62/sh−25,000$640,500→ 0 total
    Exercise: $6.38Exp: 2015-09-21→ Common Stock (25,000 underlying)
Footnotes (5)
  • [F1]Reflects shares of Santarus, Inc. ("Santarus") common stock, par value $0.0001 per share (the "Shares"), acquired in connection with the exercise of stock options effective and contingent upon the closing of the cash tender offer by Willow Acquisition Sub Corporation ("Merger Sub"), an indirect wholly owned subsidiary of Salix Pharmaceuticals, Ltd. ("Salix"), to purchase all of the issued and outstanding Shares at a purchase price of $32.00 per Share (the "Offer Price"), net to the seller in cash, without interest thereon and subject to any required withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated December 3, 2013, and in the related letter of transmittal (collectively, as each may be amended or supplemented from time to time, the "Offer").
  • [F2]Includes shares acquired by the reporting person under the Santarus, Inc. Employee Stock Purchase Plan: 624 shares on 11/29/13.
  • [F3]Reflects Shares pledged to pay the exercise price for stock options exercised effective and contingent upon the closing of the Offer.
  • [F4]Reflects stock options to purchase Shares. In connection with the merger (the "Merger") of Merger Sub with and into Santarus pursuant to the Agreement and Plan of Merger, dated as of November 7, 2013 (the "Merger Agreement"), among Salix, Salix Pharmaceuticals, Inc., Merger Sub and Santarus, such stock options (i) became fully vested and exercisable prior to the effective time of the Merger and (ii) to the extent not exercised on or prior to the effective time, were cancelled and converted into the right to receive a cash payment in the amount by which the Offer Price exceeded the exercise price of the stock option as of the effective time of the Merger.
  • [F5]Reflects stock options exercised effective and contingent upon the closing of the Offer.

Documents

1 file

Issuer

SANTARUS INC

CIK 0001172480

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001172480

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:27 PM ET
Size
65.9 KB
View on SEC.gov